There is no absolute contraindication to using GLP-1 receptor agonists in patients with Hashimoto's disease or established hypothyroidism
Zutaten Inhaltsstoffe (pro 2 Kapseln): CaroleanTM [Johannisbrotkernmehl (Ceratonia siliqua L.) und Feigenkaktus-Extrakt (Opuntia ficus-indica (L.) Mill.) in Pulverform: 1000 mg, davon: Gesamtballaststoffe 700 mg], Kapsel (Hydroxypropylmethylcellulose), Extrakt aus der Braunalge Wakame (Undaria pinnatifida (Harvey) Suringar): 150 mg, davon Fucoxanthin 15 mg, Fllstoff: mikrokristalline Cellulose, Trennmittel: Magnesiumsalze von Speisefettsuren, BioPerine [Extrakt aus schwarzem Pfeffer (Piper nigrum L.): 10 mg, davon 95 % Piperin: 9,5 mg], Chrompicolinat (Chrom: 40 g / 100 % ETD*)
On the other hand, Wegovy, which contains semaglutide, has demonstrated average weight losses of around 14.9% after 68 weeks
The latest clinical report from Prime, The evolution of GLP-1s, delves into some of the latest insights, empowering health plans, pharmacies and members with recent research, data, trends and forecasting for these medications, which are approved to treat type 2 diabetes, obesity and cardiovascular conditions
